Decoy Therapeutics Inc.
DCOY
$5.15
-$0.29-5.33%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 339.92% | 46.46% | -75.71% | -58.88% | -58.74% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -16.98% | -72.09% | -77.27% | -51.76% | -46.52% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 267.69% | 58.66% | -61.31% | -52.28% | -54.18% |
|
|
|||||
| Total Current Assets | 267.69% | 58.66% | -61.31% | -52.28% | -54.18% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -12.43% | -12.05% | -16.79% | -35.77% | -47.09% |
| Total Assets | 265.75% | 57.99% | -60.81% | -52.10% | -54.10% |
|
|
|||||
| Total Accounts Payable | 0.38% | 565.98% | 130.43% | 105.98% | 55.42% |
| Total Accrued Expenses | 143.87% | 69.31% | 38.33% | 72.23% | -13.35% |
| Short-term Debt | -- | -- | -- | -4.02% | -23.38% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 241.94% | 97.84% | 88.59% | 84.55% | 16.33% |
|
|
|||||
| Total Current Liabilities | 241.94% | 97.84% | 88.59% | 84.55% | 16.33% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -4.02% | -23.38% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 241.94% | 97.84% | 88.59% | 84.55% | 16.33% |
|
|
|||||
| Common Stock & APIC | 20.25% | 7.59% | 2.32% | 2.43% | 2.21% |
| Retained Earnings | -15.28% | -6.22% | -6.42% | -7.14% | -7.30% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 289.56% | 45.25% | -134.93% | -98.30% | -71.41% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 289.56% | 45.25% | -134.93% | -98.30% | -71.41% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 289.56% | 45.25% | -134.93% | -98.30% | -71.41% |
|
|
|||||